Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDChromocell Therapeutics Corporation Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q2 2024 | 1 | -$0.23 | -$0.23 | -$0.23 |
| Q3 2024 | 1 | -$0.21 | -$0.21 | -$0.21 |
| Q1 2025 | 1 | -$0.29 | -$0.29 | -$0.29 |
| Q2 2025 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q3 2025 | 1 | -$0.26 | -$0.26 | -$0.26 |
| Q4 2025 | 1 | -$0.25 | -$0.25 | -$0.25 |
Chromocell Therapeutics Corporation Earnings Date And Information
Chromocell Therapeutics Corporation last posted its earnings results on Wednesday, November 13th, 2024. The company reported $-0.29 earnings per share for the quarter, missing analysts' consensus estimates of $-0.23 by $0.06. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Chromocell Therapeutics Corporation has generated $-1 earnings per share over the last year ($-1.28 diluted earnings per share) and currently has a price-to-earnings ratio of -0.37. Chromocell Therapeutics Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
Chromocell Therapeutics Corporation Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$0.23 | -$0.29 | -0.06 | $0 | $0 |
| 08/13/2024 | Q2 2024 | -$0.31 | $0 | $0 | ||
| 05/15/2024 | Q1 2024 | -$0.44 | $0 | |||
| 04/16/2024 | Q4 2023 | -$0.69 | $0 | |||
| 09/29/2023 | Q3 2023 | -$0.25 | $0 | |||
| 06/29/2023 | Q2 2023 | -$0.17 | $0 | |||
| 03/30/2023 | Q1 2023 | -$0.17 | $0 | |||
| 12/29/2022 | Q4 2022 | -$0.13 | $0 | |||
| 09/28/2022 | Q3 2022 | -$0.10 | $0 | |||
| 06/28/2022 | Q2 2022 | -$0.06 | $0 | |||
| 03/29/2022 | Q1 2022 | -$0.05 | $0 | |||
| 12/31/2021 | Q4 2021 | $0.00 | $0 | |||
| 09/30/2021 | Q3 2021 | $0.00 | $234 | |||
| 06/30/2021 | Q2 2021 | $0.00 | $0 | |||
| 03/31/2021 | Q1 2021 | $0.00 | $0 |
Chromocell Therapeutics Corporation Earnings: FAQ's
When is Chromocell Therapeutics Corporation's earnings date?
Chromocell Therapeutics Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
How can I listen to Chromocell Therapeutics Corporation's earnings conference
call?
The conference call for Chromocell Therapeutics Corporation's latest earnings report can be listened to online.
How can I read Chromocell Therapeutics Corporation's conference call transcript?
The conference call transcript for Chromocell Therapeutics Corporation's latest earnings report can be read online.
How much profit does Chromocell Therapeutics Corporation generate each year?
Chromocell Therapeutics Corporation (:CHRO) has a recorded net income of $0. Chromocell Therapeutics Corporation has generated $-1.28 earnings per share over the last four quarters.
What is Chromocell Therapeutics Corporation's price-to-earnings ratio?
Chromocell Therapeutics Corporation (:CHRO) has a price-to-earnings ratio of -0.37 and price/earnings-to-growth ratio is 0.16.